Gender Difference in the Effects of COVID-19 Pandemic on Mechanical Reperfusion and 30-Day Mortality for STEMI: Results of the ISACS-STEMI COVID-19 Registry
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
PubMed
36769546
PubMed Central
PMC9918240
DOI
10.3390/jcm12030896
PII: jcm12030896
Knihovny.cz E-zdroje
- Klíčová slova
- COVID-19, ST-segment elevation myocardial infarction, gender, percutaneous coronary intervention,
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Several reports have demonstrated the impact of the COVID-19 pandemic on the management and outcome of patients with ST-segment elevation myocardial infarction (STEMI). The aim of the current analysis is to investigate the potential gender difference in the effects of the COVID-19 pandemic on mechanical reperfusion and 30-day mortality for STEMI patients within the ISACS-STEMI COVID-19 Registry. METHODS: This retrospective multicenter registry was performed in high-volume primary percutaneous coronary intervention (PPCI) centers on four continents and included STEMI patients undergoing PPCIs in March-June 2019 and 2020. Patients were divided according to gender. The main outcomes were the incidence and timing of the PPCI, (ischemia time ≥ 12 h and door-to-balloon ≥ 30 min) and in-hospital or 30-day mortality. RESULTS: We included 16683 STEMI patients undergoing PPCIs in 109 centers. In 2020 during the pandemic, there was a significant reduction in PPCIs compared to 2019 (IRR 0.843 (95% CI: 0.825-0.861, p < 0.0001). We did not find a significant gender difference in the effects of the COVID-19 pandemic on the numbers of STEMI patients, which were similarly reduced from 2019 to 2020 in both groups, or in the mortality rates. Compared to prepandemia, 30-day mortality was significantly higher during the pandemic period among female (12.1% vs. 8.7%; adjusted HR [95% CI] = 1.66 [1.31-2.11], p < 0.001) but not male patients (5.8% vs. 6.7%; adjusted HR [95% CI] = 1.14 [0.96-1.34], p = 0.12). CONCLUSIONS: The COVID-19 pandemic had a significant impact on the treatment of patients with STEMI, with a 16% reduction in PPCI procedures similarly observed in both genders. Furthermore, we observed significantly increased in-hospital and 30-day mortality rates during the pandemic only among females. Trial registration number: NCT 04412655.
Azienda Ospedaliera Lavagna 16033 Lavagna Italy
Azienda Ospedaliero Universitaria Ospedali Riuniti 34142 Trieste Italy
Cardiology Department Hospital Garcia de Orta Pragal 2805 267 Almada Portugal
Cardiology Institute Istanbul University 34000 Instanbul Turkey
Center for Cardiovascular Diseases 6000 Ohrid North Macedonia
Center Hospitalier d'Antibes Juan Les Pins 06600 Antibes France
Central Hospital of Medical University of Lodz 90 008 Lodz Poland
Clinic Emergency Hospital of Bucharest 014461 Bucharest Romania
Complexo Hospetaliero Universitario La Coruna 15001 La Coruna Spain
Department of Cardiology Bezmialem Vakif University Hospital 34093 Istanbul Turkey
Department of Cardiology Medical Center Ljubljana 1000 Ljubljana Slovenia
Department of Cardiology Medisch Spectrum Twente Thoraxcentrum Twente 7541 Enschede The Netherlands
Department of Cardiology National Heart Center Singapore 169609 Singapore
Department of Cardiology National University Hospital Singapore 117597 Singapore
Department of Cardiology Queen Elizabeth Hospital University of Hong Kong Hong Kong
Department of Cardiology Queen Mary Hospital University of Hong Kong Hong Kong
Department of Cardiology University Hospital Centre University of Zagreb 10000 Zagreb Croatia
Department of Internal Medicine Ospedale Riuniti 25121 Brescia Italy
Department of Statistical Sciences University of Padova 35121 Padova Italy
Division of Cardiology 3584 Utrecht The Netherlands
Division of Cardiology Alexandra Hospital 10431 Athens Greece
Division of Cardiology Assiut University Heart Hospital Assiut University Asyut 71515 Egypt
Division of Cardiology Attikon University Hospital 10431 Athens Greece
Division of Cardiology AUSL IRCCS Reggio Emilia 42121 Reggio Emilia Italy
Division of Cardiology Azienda Ospedaliera Ospedali Riuniti Marche Nord 61121 Pesaro Italy
Division of Cardiology Blida University Hospital Blida 09000 Algeria
Division of Cardiology Bursa City Hospital 16000 Bursa Turkey
Division of Cardiology Center Hospitalier Universitaire de Lille 59000 Lille France
Division of Cardiology Clinica Villa dei Fiori 80011 Acerra Italy
Division of Cardiology Complejo Hospitalario de Toledo 45001 Toledo Spain
Division of Cardiology Faculty of Medicine Eskisehir Osmangazi University 02640 Eskisehir Turkey
Division of Cardiology Groupe Hospitalier Mutualiste de Grenoble 38000 Grenoble France
Division of Cardiology Heart Centre Turku 20521 Turku Finland
Division of Cardiology Hopital Erasmus Universitè Libre de Bruxelles 1070 Brussels Belgium
Division of Cardiology Hospiatl Cordoba Cordoba 5000 Argentina
Division of Cardiology Hospital Cabueñes 33201 Gijon Spain
Division of Cardiology Hospital Clinico Universitario de Valencia 46010 Valencia Spain
Division of Cardiology Hospital de Santa Cruz CHLO Nova Medical School CEDOC 1000 Lisbon Portugal
Division of Cardiology Hospital de Santo António 4099 001 Porto Portugal
Division of Cardiology Hospital Puerta de Hierro Majadahonda 28222 Majadahonda Spain
Division of Cardiology Hospital Puerta del Mar 11001 Cadiz Spain
Division of Cardiology Hospital Universitario de Canarias 38001 Santa Cruz de Tenerife Spain
Division of Cardiology Kontantopoulion Hospital 10431 Athens Greece
Division of Cardiology Medical University of Silezia 40 002 Katowice Poland
Division of Cardiology Northwest Clinics 1811 Alkmaar The Netherlands
Division of Cardiology Nuovo Galeazzi Sant'Ambrogio Hospital 20161 Milan Italy
Division of Cardiology Odense Universitets Hospital 5000 Odense Denmark
Division of Cardiology Ospedale A Manzoni 23900 Lecco Italy
Division of Cardiology Ospedale Civico Arnas 90100 Palermo Italy
Division of Cardiology Ospedale degli Infermi ASL 13900 Biella Italy
Division of Cardiology Ospedale del Mare 00156 Napoli Italy
Division of Cardiology Ospedale F Spaziani 03100 Frosinone Italy
Division of Cardiology Ospedale G Moscati 81031 Aversa Italy
Division of Cardiology Ospedale Maggiore Bologna 40100 Bologna Italy
Division of Cardiology Ospedale S Maurizio Bolzano 39100 Bolzano Italy
Division of Cardiology Ospedale San Giovanni di Dio e Ruggi d'Aragona 84070 Salerno Italy
Division of Cardiology Ospedale Sant'Anna 44121 Ferrara Italy
Division of Cardiology Ospedale Santa Chiara di Trento 38014 Trento Italy
Division of Cardiology Ospedale Santa Maria delle Grazie 80078 Pozzuoli Italy
Division of Cardiology Ospedale Santa Maria Goretti Latina 04100 Latina Italy
Division of Cardiology Otamendi Hospital Buenos Aires 1001 Argentina
Division of Cardiology Oulu University Hospital 90220 Oulu Finland
Division of Cardiology Radboud University Medical Center 6525 Nijmegen The Netherlands
Division of Cardiology St Antonius Hospital 3434 Nieuwegein The Netherlands
Division of Cardiology Universidad UPB Universidad CES Medellín 050001 Colombia
Hospital Clínico Universitario Virgen de la Victoria 29000 Malaga Spain
Hospital Germans Triasi Pujol 8918 Badalona Spain
Instituto Cardiovascular de Buenos Aires Buenos Aires 1428 Argentina
Instituto de Cardiologia de Santa Catarina Praia Comprida São José 88103 901 Brazil
Instituto de Cardiologia do Rio Grande do Sul Porto Alegre 90040 371 Brazil
Instituto de Cardiologia Integral Montevideo 11700 Uruguay
Interventional Cardiology Unit Azienda Ospedaliera Sanitaria 43121 Parma Italy
Interventional Cardiology Unit Azienda Ospedaliero Universitaria Ospedali Riuniti 60100 Ancona Italy
Invasive Cardiology and Congenital Heart Disease Patras University Hospital 26221 Patras Greece
Iraklion University Hospital 70001 Crete Greece
Maastricht University Medical Center 6229 Maastricht The Netherlands
Sección de la Unidad de Hemodinámica H Universitario y Politécnico La Fe 46001 Valencia Spain
University Hospital Brno Medical Faculty of Masaryk University 60200 Brno Czech Republic
Zobrazit více v PubMed
Axenhus M., Schedin-Weiss S., Winblad B., Wimo A. Changes in mortality trends amongst common diseases during the COVID-19 pandemic in Sweden. Scand. J. Public Health. 2021;50:748–755. doi: 10.1177/14034948211064656. PubMed DOI PMC
Coronavirus (COVID-19) Deaths. [(accessed on 31 January 2022)]. Available online: https://ourworldindata.org/covid-deaths.
Garcia S., Albaghdadi M.S., Meraj P.M., Schmidt C., Garberich R., Jaffer F.A., Dixon S., Rade J.J., Tannenbaum M., Chambers J., et al. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States during COVID-19 Pandemic. J. Am. Coll. Cardiol. 2020;75:2871–2872. doi: 10.1016/j.jacc.2020.04.011. PubMed DOI PMC
Tam C.F., Cheung K.S., Lam S., Wong A., Yung A., Sze M., Lam Y.M., Chan C., Tsang T.C., Tsui M., et al. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China. Circ. Cardiovasc Qual. Outcomes. 2020;13:e006631. doi: 10.1161/CIRCOUTCOMES.120.006631. PubMed DOI PMC
Piccolo R., Bruzzese D., Mauro C., Aloia A., Baldi C., Boccalatte M., Bottiglieri G., Briguori C., Caiazzo G., Calabrò P., et al. Population Trends in Rates of Percutaneous Coronary Revascularization for Acute Coronary Syndromes Associated with the COVID-19. Outbreak Circ. 2020;141:2035–2037. doi: 10.1161/CIRCULATIONAHA.120.047457. PubMed DOI PMC
Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M., Metra M., Curello S., Maffeo D., Pero G., et al. ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic. Outcomes Circ. 2020;141:2113–2116. doi: 10.1161/CIRCULATIONAHA.120.047525. PubMed DOI PMC
De Luca G., Suryapranata H., Ottervanger J.P., Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: Every minute of delay counts. Circulation. 2004;109:1223–1225. doi: 10.1161/01.CIR.0000121424.76486.20. PubMed DOI
Jain V., Gupta K., Bhatia K., Bansal A., Arora S., Khandelwal A.K., Rosenberg J.R., Levisay J.P., Tommaso C.L., Ricciardi M.J., et al. Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021. Trends Cardiovasc. Med. 2021;31:135–140. doi: 10.1016/j.tcm.2020.12.003. PubMed DOI PMC
De Luca G., Verdoia M., Cercek M., Jensen L.O., Vavlukis M., Calmac L., Johnson T., Ferrer G.R., Ganyukov V., Wojakowski W., et al. Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI. J. Am. Coll. Cardiol. 2020;76:2321–2330. doi: 10.1016/j.jacc.2020.09.546. PubMed DOI PMC
Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069. doi: 10.1001/jama.2020.1585. PubMed DOI PMC
Cai H. Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med. 2020;8:e20. doi: 10.1016/S2213-2600(20)30117-X. PubMed DOI PMC
Ferrante G., Barbieri L., Sponzilli C., Lucreziotti S., Salerno Uriarte D., Centola M., Verdoia M., Carugo S. Predictors of Mortality and Long-Term Outcome in Patients with Anterior STEMI: Results from a Single Center Study. J. Clin. Med. 2021;10:5634. doi: 10.3390/jcm10235634. PubMed DOI PMC
Verdoia M., Suryapranata H., Damen S., Camaro C., Benit E., Barbieri L., Rasoul S., Liew H.B., Polad J., Ahmad W.A.W., et al. Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial. J. Thromb. Thrombolysis. 2021;52:797–807. doi: 10.1007/s11239-021-02439-x. PubMed DOI
Silverio A., Di Maio M., Citro R., Esposito L., Iuliano G., Bellino M., Baldi C., De Luca G., Ciccarelli M., Vecchione C., et al. Cardiovascular risk factors and mortality in hospitalized patients with COVID-19: Systematic review and meta-analysis of 45 studies and 18,300 patients. BMC Cardiovasc. Disord. 2021;21:23. doi: 10.1186/s12872-020-01816-3. PubMed DOI PMC
Gelman A., Hill J. Data Analysis Using Regression and Multilevel/Hierarchical Models. Cambridge University Press; New York, NY, USA: 2007.
De Luca G., Suryapranata H., Dambrink J.H., Ottervanger J.P., van ‘t Hof A.W., Zijlstra F., Hoorntje J.C., Gosselink A.T., de Boer M.J. Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: Data from the Zwolle Myocardial Infarction study. Am. Heart J. 2004;148:852–856. doi: 10.1016/j.ahj.2004.05.018. PubMed DOI
Paradossi U., Taglieri N., Massarelli G., Palmieri C., De Caterina A.R., Bruno A.G., Taddei A., Nardi E., Ghetti G., Palmerini T., et al. Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI. J. Cardiovasc. Med. 2022;23:234–241. doi: 10.2459/JCM.0000000000001300. PubMed DOI
De Luca G., Parodi G., Sciagrà R., Bellandi B., Verdoia M., Vergara R., Migliorini A., Valenti R., Antoniucci D. Relation of gender to infarct size in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty. Am. J. Cardiol. 2013;111:936–940. doi: 10.1016/j.amjcard.2012.12.011. PubMed DOI
De Luca G., Gibson C.M., Gyöngyösi M., Zeymer U., Dudek D., Arntz H.R., Bellandi F., Maioli M., Noc M., Zorman S., et al. Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: Insights from the EGYPT cooperation. J. Thromb. Thrombolysis. 2010;30:342–346. doi: 10.1007/s11239-010-0451-y. PubMed DOI
De Luca G., Verdoia M., Dirksen M.T., Spaulding C., Kelbæk H., Schalij M., Thuesen L., Hoeven Bv Vink M.A., Kaiser C., Musto C., et al. Gender-related differences in outcome after BMS or DES implantation in patients with ST-segment elevation myocardial infarction treated by primary angioplasty: Insights from the DESERT cooperation. Atherosclerosis. 2013;230:3056. doi: 10.1016/j.atherosclerosis.2013.05.024. PubMed DOI
Chew N.W., Sia C.H., Wee H.L., Benedict L.J., Rastogi S., Kojodjojo P., Chor W.P.D., Leong B.S., Koh B.C., Tam H., et al. Impact of the COVID-19 Pandemic on Door-to-Balloon Time for Primary Percutaneous Coronary Intervention–Results From the Singapore Western STEMI Network. Circ. J. 2021;85:139–149. doi: 10.1253/circj.CJ-20-0800. PubMed DOI
Xiang D., Xiang X., Zhang W., Yi S., Zhang J., Gu X., Xu Y., Huang K., Su X., Yu B., et al. Management and Outcomes of Patients With STEMI During the COVID-19 Pandemic in China. J. Am. Coll. Cardiol. 2020;76:1318–1324. doi: 10.1016/j.jacc.2020.06.039. PubMed DOI PMC
De Luca G., Cercek M., Jensen L.O., Vavlukis M., Calmac L., Johnson T., Roura IFerrer G., Ganyukov V., Wojakowski W., von Birgelen C., et al. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: Insights from the ISACS STEMI COVID 19 Registry. Cardiovasc. Diabetol. 2020;19:215. doi: 10.1186/s12933-020-01196-0. PubMed DOI PMC
Rangé G., Hakim R., Beygui F., Angoulvant D., Marcollet P., Godin M., Deballon R., Bonnet P., Fichaux O., Barbey C., et al. Incidence, delays, and outcomes of STEMI during COVID-19 outbreak: Analysis from the France PCI registry. J. Am. Coll. Emerg. Physicians Open. 2020;1:1168–1176. doi: 10.1002/emp2.12325. PubMed DOI PMC
Meisel S.R., Tal O., Kobo O., Saada M., Nashed H., Fanne R.A., Alcalai R., Amsalem N., Levi Y., Mohsen J., et al. Impact of the Admission Pathway on the Gender-Related Mortality of Patients With ST-Elevation Myocardial Infarction. Am. J. Cardiol. 2022;166:9–17. doi: 10.1016/j.amjcard.2021.11.025. PubMed DOI
Verdoia M., Viglione F., Boggio A., Stefani D., Panarotto N., Malabaila A., Rolla R., Soldà P.L., De Luca G. Novara Atherosclerosis Study Group (NAS). Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention. Vasc. Pharmacol. 2021;140:106897. doi: 10.1016/j.vph.2021.106897. PubMed DOI
Mo P., Xing Y., Xiao Y., Deng L., Zhao Q., Wang H., Xiong Y., Cheng Z., Gao S., Liang K., et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin. Infect. Dis. 2021;73:e4208–e4213. doi: 10.1093/cid/ciaa270. PubMed DOI PMC
Gebhard C., Regitz-Zagrosek V., Neuhauser H.K., Morgan R., Klein S.L. Impact of sex and gender on COVID-19 outcomes in Europe. Biol. Sex. Differ. 2020;11:29. doi: 10.1186/s13293-020-00304-9. PubMed DOI PMC
Galloway J.B., Norton S., Barker R.D., Brookes A., Carey I., Clarke B.D., Jina R., Reid C., Russell M.D., Sneep R., et al. A clinical risk score to identify patients with COVID-19 at high risk of critical care admission or death: An observational cohort study. J. Infect. 2020;81:282–288. doi: 10.1016/j.jinf.2020.05.064. PubMed DOI PMC
Megiorni F., Pontecorvi P., Gerini G., Anastasiadou E., Marchese C., Ceccarelli S. Sex-Related Factors in Cardiovascular Complications Associated to COVID-19; Sex differences underlying preexisting cardiovascular disease and cardiovascular injury in COVID-19. Biomolecules. 2021;12:21. doi: 10.3390/biom12010021. PubMed DOI PMC
Fischer M., Baessler A., Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc. Res. 2002;53:672–677. doi: 10.1016/S0008-6363(01)00479-5. PubMed DOI
Chappell M.C., Marshall A.C., Alzayadneh E.M., Shaltout H.A., Diz D.I. Update on the angiotensin converting enzyme 2-angiotensin (1-7)-Mas receptor axis: Fetal programing, sex differences, and intracellular pathways. Front. Endocrinol. 2014;4:201. doi: 10.3389/fendo.2013.00201. PubMed DOI PMC
De Rosa S., Spaccarotella C., Basso C., Calabrò M.P., Curcio A., Filardi P.P., Mancone M., Mercuro G., Muscoli S., Nodari S., et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Società Italiana di Cardiologia and the CCU Academy investigators group. Eur. Heart J. 2020;41:2083–2088. doi: 10.1093/eurheartj/ehaa409. PubMed DOI PMC
Barbero U., Moncalvo C., Trabattoni D., Pavani M., Amoroso G.R., Bocchino P.P., Giachet A.T., Saglietto A., Monticone S., Secco G.G., et al. Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak. Am. J. Cardiovasc. Dis. 2020;10:506–513. PubMed PMC
Huynh J., Barmano N., Karlsson J.E., Stomby A. Sex and age differences in the incidence of acute myocardial infarction during the COVID-19 pandemic in a Swedish health-care region without lockdown: A retrospective cohort study. Lancet. 2021;2:e283–e289. doi: 10.1016/S2666-7568(21)00085-4. PubMed DOI